We use cookies to help us improve the website and your experience using it. You may delete and block all cookies from this site at any time. However, please note this may result in parts of the site no longer working correctly. If you continue without changing your settings we will assume you are happy to receive all cookies on this site.


Heritable bleeding disorders

The MDC has close links with the Comprehensive Care Haemophilia Centres at Manchester Royal Infirmary (MRI) and the Royal Manchester Children's Hospital (RMCH). Genetic diagnosis in heritable bleeding disorders, including clinical scientific interpretation of individual cases, is provided to these haemophilia centres and also, as required, to other centres nationally and internationally.

Comprehensive genetic diagnosis is presently available for haemophilia A, haemophilia B, von Willebrand disease (VWD), FXI deficiency, and FVII deficiency.

Informed consent

It is the referring clinician's responsibility to obtain and record informed consent prior to genetic diagnosis in all heritable bleeding disorders. In this regard, it is also the referring clinician's responsibility to inform the laboratory of any restrictions on consent (for example to store genetic information on confidential databases, or to apply an individual's genetic information in the diagnosis of other family members). A standard consent form and patient information leaflet is in use within the CMFT Comprehensive Care Haemophilia Centres.


(Last reviewed 12th February 2018)